Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Takeda presents new series for androgen- or estrogen-dependent disorders

Nov. 19, 1999

Results of Aptosyn trial show inhibition of rise in PSA levels in prostate cancer patients

Nov. 19, 1999

Ribozyme and Chiron initiate phase I/II studies of Angiozyme

Nov. 18, 1999

Somatostatin receptor ligands synthesized and tested at Takeda

Nov. 18, 1999

ImmunoGen options antibody from Duke and Johns Hopkins

Nov. 18, 1999

RPR/INGN-201 + radiotherapy provides supraadditive effects in prostate cancer xenograft models

Nov. 17, 1999

Lorus files IND seeking clearance for phase I/II clinical trials of GTI-2040

Nov. 17, 1999

Foscan receives orphan drug designation in U.S.; MAA accepted in E.U.

Nov. 17, 1999

Pharmaceutical agents useful as vitronectin antagonists and methods of use

Nov. 17, 1999

Kinase inhibitors developed at Boehringer Ingelheim as potential anticancer agents

Nov. 17, 1999

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...